Akamara Biomedicine

India Founded: 2019 • Age: 7 yrs
Develops innovative therapeutics for cancer treatment.

About Akamara Biomedicine

Akamara Biomedicine was a Healthcare company based in India founded in 2019. It develops innovative therapeutics for cancer treatment. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Therapeutics and Cancer Treatment.

Company details

Akamara Biomedicine operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for cancer treatment. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters India
  • Sectors
    Healthcare
  • Website akamara.in
Key Metrics
  • Annual Revenue
    $413.96 K (USD)
    as on Mar 31, 2021

Board of directors of Akamara Biomedicine

The boards of the 2 registered companies of Akamara Biomedicine currently have 5 directors; the longest-serving is Raghunath Anant Mashelkar, appointed in 2017. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Raghunath Anant Mashelkar
DIN 00074119
Director30 Aug 20179 yrs 2 moAkamara Biomedicine Private Limited
Shiladitya Sengupta
DIN 01837274
Director30 Aug 20179 yrs 2 moAkamara Biomedicine Private Limited
Shrikant Mantri
DIN 01240147
Designated Partner13 Jul 20188 yrs 4 moNavam Technology Ventures Llp, Akamara Biomedicine Private Limited
Rajeev Mantri
DIN 01895901
Designated Partner13 Jul 20188 yrs 4 moNavam Technology Ventures Llp, Akamara Biomedicine Private Limited
Sonam Mantri
DIN 08087804
Designated Partner13 Jul 20188 yrs 4 moNavam Technology Ventures Llp

Financials of Akamara Biomedicine

Figures of Akamara Biomedicine Private Limited, the primary company behind Akamara Biomedicine, for FY 2024. Revenue was ₹9,100 (-93% year on year). Net loss was -₹34,191 (-376% margin). EBITDA was -₹34,191 (-376% margin). Revenue has grown at a compounded annual rate of -93% over three years.

  • ₹9,100Revenue · FY 2024 · -93% YoY
  • -₹34,191Net loss · -376% margin
  • -₹34,191EBITDA · -376% margin
  • ₹1 LakhPaid-up capital
  • 37Employees (provident fund records)
  • -93%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Akamara Biomedicine Private Limited are on its company page.

Premium access

Detailed financial statements for Akamara Biomedicine

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Akamara Biomedicine

Akamara Biomedicine was founded in 2019.

Akamara Biomedicine is headquartered in India.

Annual revenue of Akamara Biomedicine is $413.96K as on Mar 31, 2021.

Akamara Biomedicine operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and cancer treatment. Develops innovative therapeutics for cancer treatment. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations. It continues to evolve, meeting industry challenges with strategic approaches.

Akamara Biomedicine is associated with 2 legal entities: Navam Technology Ventures Llp, Akamara Biomedicine Private Limited.

The legal entities of Akamara Biomedicine currently have 5 directors, including Shrikant Mantri, Rajeev Mantri, Sonam Mantri and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available